top of page

HELP 4 HD INTERNATIONAL

Stand Up Speak Up 4 HD 🎉 Click Here

Search

uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational Gene Therapy AMT-130 in Huntington’s Disease

katie8288
Jun 3, 2024
0 min read

Recent Posts

Skyhawk Therapeutics Announces the Expansion of its Global Pivotal trial into the United States, Canada, and the United Kingdom

Skyhawk Therapeutics Announces the Expansion of its Global Pivotal trial into the United States, Canada, and the United Kingdom

Update on Two Clinical Studies: GENERATION HD2 (tominersen) and POINT-HD (RG6496)

Update on Two Clinical Studies: GENERATION HD2 (tominersen) and POINT-HD (RG6496)

Prilenia and Ferrer Announce Initiation of the Confirmatory PRECISE-HD Study of Pridopidine in Huntington’s Disease

Prilenia and Ferrer Announce Initiation of the Confirmatory PRECISE-HD Study of Pridopidine in Huntington’s Disease

Comments

bottom of page